Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Skin Neoplasms × Tacrolimus × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 93 Myelodysplastic Syndromes 90 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Lymphoma, Non-Hodgkin 60 Leukemia 60 Multiple Myeloma 59 Hodgkin Disease 59 Leukemia, Lymphocytic, Chronic, B-Cell 56 Lymphoma 54 Myeloproliferative Disorders 43 Graft vs Host Disease 41 Hematologic Neoplasms 40 Lymphoma, Follicular 39 Leukemia, Myeloid, Accelerated Phase 38 Lymphoma, Mantle-Cell 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37 Lymphoma, Large B-Cell, Diffuse 36 Leukemia, Myelomonocytic, Chronic 36 Lymphoma, B-Cell, Marginal Zone 34 Congenital Abnormalities 34 Burkitt Lymphoma 34 Primary Myelofibrosis 31 Leukemia, Myeloid, Chronic-Phase 31 Blast Crisis 31 Neoplasms, Plasma Cell 30 Lymphoma, Large-Cell, Immunoblastic 27 Lymphoma, T-Cell, Cutaneous 20 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20 Waldenstrom Macroglobulinemia 19 Myelodysplastic-Myeloproliferative Diseases 19

Interventions

Nivolumab 12 Ipilimumab 10 pembrolizumab 8 Surveys and Questionnaires 6 Biopsy 6 cemiplimab 5 Radiotherapy 5 Blood Specimen Collection 5 aldesleukin 4 Photochemotherapy 4 Interleukin-2 4 Fluorouracil 4 Educational Status 4 avelumab 3 Vemurafenib 3 Temozolomide 3 Surgical Procedures, Operative 3 Sirolimus 3 Radiation 3 Petrolatum 3 Cyclophosphamide 3 Cetuximab 3 Aminolevulinic Acid 3 trametinib 2 sonidegib 2 fludarabine phosphate 2 fludarabine 2 dabrafenib 2 atezolizumab 2 Vinblastine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated

44 enrolled 7 charts

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡